Cutler Group LP Puma Biotechnology, Inc. Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 07, 2020	SELL	$6.28 - $14.57 $2,512 - $5,828	-400 Reduced 30.77%	900 $0
Q2 2019 Aug 09, 2019	SELL	$12.3 - $35.76 $44,280 - $128,736	-3,600 Reduced 73.47%	1,300 $0
Q1 2019 May 10, 2019	SELL	$20.77 - $42.37 $93,465 - $190,665	-4,500 Reduced 47.87%	4,900 $18,000
Q3 2018 Nov 07, 2018	SELL	$41.2 - $59.85 $103,000 - $149,625	-2,500 Reduced 21.01%	9,400 $76,000
Q2 2018 Aug 10, 2018	SELL	$48.3 - $68.25 $154,560 - $218,400	-3,200 Reduced 21.19%	11,900 $134,000
Q1 2018 May 11, 2018	BUY	$59.7 - $99.25 $125,370 - $208,425	2,100 Added 16.15%	15,100 $238,000
Q4 2017 Jan 17, 2018	SELL	$93.85 - $132.45 $103,235 - $145,695	-1,100 Reduced 7.8%	13,000 $308,000
Q3 2017 Oct 17, 2017	BUY	$72.0 - $119.75 $1.02 Million - $1.69 Million	14,100	14,100 $634,000

101

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $136M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.